Arbutus Biopharma Corp (ABUS) Habari na Bei za Hisa

MwanzoABUS • NASDAQ

Arbutus Biopharma Corp

$ 4.26

16 Mac, 08:20:34 GMT -4 · USD · NASDAQ · Kanusho

HisaHisa zinazouzwa MarekaniMakao yake makuu ni Marekani

Bei iliyotangulia

$ 4.26

Bei za mwaka

$ 2.71 - $ 5.10

Thamani ya kampuni katika soko

819.30M USD

Wastani wa hisa zilizouzwa

2.67M

Uwiano wa bei na mapato

Mgao wa faida

Ubadilishanaji wa msingi

NASDAQ

Habari za soko

GlobeNewswire

dakika 15 zilizopita

JFB (NASDAQ: JFB) Announces XTEND and Rayonix Execute

New to The Street Broadcasts Episode Featuring FreeCast (NASDAQ:CAST), KLED.AI, PetVivo (OTCQB:PETV), EmpowerLit, and BlackBarn NYC on Bloomberg Television - March 21 at 6:30 PM EST

Quipt Home Medical (NASDAQ: QIPT) delists common shares via Form 25

Trump has 15 days to end the Iran war or markets face a brutal April repricing — from oil to the S&P 500

Severe oil shock could drag S&P 500 down to 5,400, Goldman warns

Acadia Pharmaceuticals Rings the Opening Bell

ACAD

0.00%

Kuhusu

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia

Afisa Mkuu Mtendaji (CEO)

William H. Collier

Ilianzishwa

2007

Makao Makuu

Warminster Township, Pennsylvania
Marekani

Tovuti

arbutusbio.com

Wafanyakazi